New study investigates dangerous clots on heart implants
NCT ID NCT06177704
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study follows 100 people who have developed a blood clot on a device placed to close the left atrial appendage, a common procedure to prevent stroke. Researchers want to learn how often these clots come back or persist, what factors contribute to them, and whether they lead to strokes or other serious events. Participants will undergo regular imaging and be monitored for up to two years.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this study could lead to better guidelines for monitoring and managing blood clots after left atrial appendage closure, potentially reducing stroke risk.
What could go wrong
This is an observational study, not a treatment trial. It will not directly test a new therapy, and results may not change practice immediately.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PERCUTANEOUS LEFT ATRIAL APPENDAGE OCCLUSION (LAAO) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
IUCPQ-UL
Québec, Quebec, G1V 4G5, Canada
Contact Phone: •••-•••-•••• Email: •••••@•••••